Among those, evidence that upstream to its abnormal proteolysis, full-length APP is overexpressed in familiar (Johnston et al., 1994; Vignini et al., 2013) and sporadic (Matsui et al., 2007) AD patients, and in their respective murine models (Howlett and Richardson, 2009) is getting an increased interest. This evidence concerns the gene APP and Alzheimer disease.